Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Phenylketonuria
Related studies linked through entity extraction aliases.
The Effects of Kuvan on Functional Brain Connectivity in Individuals With Phenylketonuria (PKU)
- Status
- COMPLETED
- Phase
- N/A
Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU
- Status
- COMPLETED
- Phase
- PHASE2
Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
- Status
- COMPLETED
- Phase
- PHASE2
Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria
- Status
- COMPLETED
- Phase
- NA
The Effect of Supplemental Docosahexaenoic Acid (DHA) on Neurocognitive Outcomes in Teen and Adult Women With Phenylketonuria(PKU)
- Status
- COMPLETED
- Phase
- NA
Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU
- Status
- COMPLETED
- Phase
- PHASE3
Behavioral Effects of Kuvan in Children With Mild Phenylketonuria
- Status
- TERMINATED
- Phase
- N/A
A Phase 1 Study to Evaluate Effects of Sapropterin Dihydrochloride on QTc Intervals in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
- Status
- COMPLETED
- Phase
- N/A
Sapropterin in Individuals With Phenylketonuria
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors
- Status
- COMPLETED
- Phase
- N/A
Nutritional and Neurotransmitter Changes in PKU Subjects on BH4
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
- Status
- COMPLETED
- Phase
- PHASE1
Sapropterin Expanded Access Program
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006
- Status
- COMPLETED
- Phase
- PHASE3
The Early History of Universal Screening for Metabolic Disorders
- Status
- COMPLETED
- Phase
- N/A
Study of BH4, a New and Simple Treatment of Mild PKU
- Status
- COMPLETED
- Phase
- PHASE2
Response to Phenylketonuria to Tetrahydrobiopterin (BH4)
- Status
- TERMINATED
- Phase
- PHASE1